(6-(Trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)methanamine hydrochloride, 5g

Ethyl 7-octenoate, 97.0%, 250mg

5-Bromo-2-iodo-3-methylpyridine, 95.0%, 5g

2-Methoxybenzaldehyde, 99.00%, 500g

TMS-HT Kit (=HMDS and TMCS in Anhydrous Pyridine) 1 mL * 8 / Reaction vial, capacity 2 mL * 8 [Trimethylsilylating Reagent, for OH compounds]1kit

5-Acetamido-2-methylbenzoic acid, 97%, 5g

2-(2,5-Dichlorofuran-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 5g

4,6-Dimethylnicotinic acid, 95.0%, 250mg

(S)-tert-Butyl (1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl)carbamate, 95.0%, 1g

(3R,7aR)-3-(tert-Butyl)-1,5-dioxohexahydropyrrolo[1,2-c]oxazole-7a-carbaldehyde, 97.0%, 100mg

(R)-2-((tert-butoxycarbonyl)amino)-2-(naphthalen-2-yl)acetic acid, 95%, 250mg

1-(Bromomethyl)-2,4-dimethylbenzene, 95.0%, 10g

Methyl 5-(tert-butyl)-2-hydroxybenzoate, 98%, 250mg